VALENSCION Trademark

Trademark Overview

On Tuesday, February 13, 2018, a trademark application was filed for VALENSCION with the United States Patent and Trademark Office. The USPTO has given the VALENSCION trademark a serial number of 87796359. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2019. This trademark is owned by Nautilus Holdco, Inc.. The VALENSCION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; scientific research; biological research; chemical research; pharmaceutical research services; pharmaceutical research and development; product research and development; medical and scientific research in the area of oligonucleotides or chemical products; medical and scientific research in the area of the structure-based drug design; biological and chemical research in the field of immunology, virology, oncology and hereditary diseases; medical and scientific research in the area of small molecule chemicals aimed at inhibiting cellular proteins for use as therapeutic agents; pharmaceutical research and development in the field of infectious diseases and disorders, cancer, viral diseases and disorders, inflammatory diseases and disorders, immunological diseases and disorders, autoimmune diseases and disorders, hereditary diseases and disorders, and cardiovascular diseases and disorders
valenscion

General Information

Serial Number87796359
Word MarkVALENSCION
Filing DateTuesday, February 13, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 3, 2018

Trademark Statements

Goods and ServicesMedical research; scientific research; biological research; chemical research; pharmaceutical research services; pharmaceutical research and development; product research and development; medical and scientific research in the area of oligonucleotides or chemical products; medical and scientific research in the area of the structure-based drug design; biological and chemical research in the field of immunology, virology, oncology and hereditary diseases; medical and scientific research in the area of small molecule chemicals aimed at inhibiting cellular proteins for use as therapeutic agents; pharmaceutical research and development in the field of infectious diseases and disorders, cancer, viral diseases and disorders, inflammatory diseases and disorders, immunological diseases and disorders, autoimmune diseases and disorders, hereditary diseases and disorders, and cardiovascular diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNautilus Holdco, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808
Party NameNautilus Holdco, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808

Trademark Events

Event DateEvent Description
Monday, April 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2018ASSIGNED TO EXAMINER
Thursday, February 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 16, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

valenscion research diseases disorders scientific medical area development chemical pharmaceutical hereditary